STOCK TITAN

Ascendis Pharma: T. Rowe Price reports 12.4% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Ascendis Pharma A/S (ASND) is the issuer of ADRs for which T. Rowe Price Investment Management, Inc. reported 8,194,812 ADRs, or 12.4% of the class, as beneficially owned as of September 30, 2026. The adviser reported sole voting power over 7,767,048 ADRs and sole dispositive power over 8,194,812, with no shared voting or dispositive power, while expressly denying that it is the beneficial owner. T. Rowe Price Capital Appreciation Fund was identified as having an interest in 3,951,747 ADRs, representing 6.0% of the class, and rights to dividends and sale proceeds from the securities it holds.

Beneficially owned ADRs 8,194,812 ADRs T. Rowe Price Investment Management reported 12.4% of the class as of September 30, 2026.
Sole voting power 7,767,048 ADRs Reported by T. Rowe Price Investment Management as of September 30, 2026.
Sole dispositive power 8,194,812 ADRs Reported by T. Rowe Price Investment Management as of September 30, 2026.
Fund interest 3,951,747 ADRs T. Rowe Price Capital Appreciation Fund; 6.0% of the class.
beneficial ownership regulatory
"beneficial ownership is expressly denied"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole voting power regulatory
"Sole voting power 7,767,048.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole Dispositive Power 8,194,812.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ASND ADRs did T. Rowe Price Investment Management report?

T. Rowe Price Investment Management reported 8,194,812 ADRs, or 12.4% of the class, as beneficially owned as of September 30, 2026. It reported sole voting power over 7,767,048 ADRs and sole dispositive power over 8,194,812 ADRs, and expressly denied beneficial ownership.

What percentage of ASND did T. Rowe Price Capital Appreciation Fund report holding?

T. Rowe Price Capital Appreciation Fund reported an interest in 3,951,747 ADRs, representing 6.0% of the class. The fund has the right to receive or direct the receipt of dividends and sale proceeds from the securities it holds.

Who has rights to dividends and sale proceeds from ASND ADRs managed by T. Rowe Price Investment Management?

The clients or their custodians or trustee banks have the right to receive dividends and sale proceeds. The clients hold the ultimate power to direct receipt of those amounts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





04351P101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/16/2026

Keep reading